Citation Impact
Citing Papers
Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells
2015 Standout
miR-221 Silencing Blocks Hepatocellular Carcinoma and Promotes Survival
2011
Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial
2012
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies
2007
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
2005 Standout
Management of hepatitis B
2007
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Toll-like receptors mediate proliferation and survival of multiple myeloma cells
2006
American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
2014
Reactivation of hepatitis B # †
2009
Targeted therapy of hepatocellular carcinoma: Present and future
2012
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
The progress and prospects of routine prophylactic antiviral treatment in hepatitis B-related hepatocellular carcinoma
2015
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Mesoporous silica nanoparticles in biomedical applications
2012 StandoutNobel
A robust cell culture system supporting the complete life cycle of hepatitis B virus
2017 StandoutNobel
Systemic chemotherapy for hepatocellular carcinoma in non-cirrhotic liver: A retrospective study
2009
TT Viruses: Oncogenic or Tumor-Suppressive Properties?
2008 StandoutNobel
Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy
2001
High Prevalence of Torque Teno (TT) Virus in Classical Kaposi's Sarcoma
2007
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Asian‐Pacific consensus statement on the management of chronic hepatitis B: An update*
2003
Short‐ and long‐term complications of open radical prostatectomy according to the Clavien classification system
2008
Hepatitis B virus DNA levels and outcomes in chronic hepatitis B # †
2009
Replication of TT virus in hepatocyte and leucocyte cell lines
2005
Prognosis prediction and staging
2014
Hepatitis B virus infection
2009 Standout
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
Hepatitis B virus X protein induces hypermethylation of p16INK4Apromoter via DNA methyltransferases in the early stage of HBV-associated hepatocarcinogenesis
2009
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
2014
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Efficacy of accelerated hepatitis B vaccination program in patients being actively treated for hematologic malignancies
2007
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival
2019
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
Pegylated liposomal doxorubicin and gemcitabine in patients with advanced hepatocellular carcinoma
2010
Hepatitis B reactivation after chemotherapy: two decades of clinical research
2008
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018
Comparison of Chemoembolization with and without Radiation Therapy and Sorafenib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Propensity Score Analysis
2015
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
2006 Standout
Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report
2009
Chronic hepatitis B
2007 Standout
Chronic hepatitis B: Update 2009 #
2009 Standout
Role of viral factors in the natural course and therapy of chronic hepatitis B
2007
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Virus target cell conditioning model to explain some epidemiologic characteristics of childhood leukemias and lymphomas
2005 StandoutNobel
Hepatocellular Carcinoma
2011
Transcription of HERV-E and HERV-E-related sequences in malignant and non-malignant human haematopoietic cells
2008 StandoutNobel
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Treatment of intermediate-stage hepatocellular carcinoma
2014
Genomic Analysis Reveals a Potential Role for Cell Cycle Perturbation in HCV-Mediated Apoptosis of Cultured Hepatocytes
2009 StandoutNobel
Prevention of Hepatitis B reactivation in the setting of immunosuppression
2016
Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment
2016
Molecular therapies and precision medicine for hepatocellular carcinoma
2018
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
2002 Standout
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA
2015 StandoutNobel
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Medical treatments for hepatocellular carcinoma (HCC): what’s next?
2006
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Doxorubicin Plus Sorafenib vs Doxorubicin Alone in Patients With Advanced Hepatocellular Carcinoma
2010
Hepatocellular Carcinoma
2011 Standout
Renal cell carcinoma
2017 Standout
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Hepatocellular carcinoma
2022 Standout
Torque Teno Virus (SANBAN Isolate) ORF2 Protein Suppresses NF-κB Pathways via Interaction with IκB Kinases
2007
TT virus-derived apoptosis-inducing protein induces apoptosis preferentially in hepatocellular carcinoma-derived cells
2004
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
2006
Hepatocellular Carcinoma
2019 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Fulminant Hepatic Failure with Hepatitis B Virus Reactivation after Rituximab Treatment in a Patient with Resolved Hepatitis B
2010
Lyso-Thermosensitive Liposomal Doxorubicin: An Adjuvant to Increase The Cure Rate of Radiofrequency Ablation in Liver Cancer
2011
Prevention and Treatment of Cancer-Related Infections
2012
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
In Vivo and In Vitro Intragenomic Rearrangement of TT Viruses
2007
Ipilimumab Administration in Patients With Advanced Melanoma and Hepatitis B and C
2013
Entecavir vs Lamivudine for Prevention of Hepatitis B Virus Reactivation Among Patients With Untreated Diffuse Large B-Cell Lymphoma Receiving R-CHOP Chemotherapy
2014
Phase II Study of Gemcitabine and Oxaliplatin in Combination With Bevacizumab in Patients With Advanced Hepatocellular Carcinoma
2006
Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease
2000 Standout
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference
2020
Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
2008
A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues
2006
EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure
2017
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Comparison of hepatocellular carcinoma in E astern versus W estern populations
2016
Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia
2013
Isolation of Multiple TT Virus Genotypes from Spleen Biopsy Tissue from a Hodgkin's Disease Patient: Genome Reorganization and Diversity in the Hypervariable Region
2004 StandoutNobel
Works of Pun Hui being referenced
A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular Carcinoma
2005
Frequent detection of the replicative form of TT virus DNA in peripheral blood mononuclear cells and bone marrow cells in cancer patients
2002
Acute toxicity of adjuvant doxorubicin and cyclophosphamide for early breast cancer – a retrospective review of Chinese patients and comparison with an historic Western series
2002
Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factors
2000
Gross Elevation of TT Virus Genome Load in the Peripheral Blood Mononuclear Cells of Cancer Patients
2001
Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients
2004
Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: A prospective study
2003
Hepatitis B viral load predicts survival of HCC patients undergoing systemic chemotherapy
2007